BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2539289)

  • 1. [The familial carcinoma burden and indications for subcutaneous mastectomy].
    Müller A; Tschahargane C; Schmidt W
    Dtsch Med Wochenschr; 1989 Apr; 114(15):575-9. PubMed ID: 2539289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subcutaneous mastectomy: surgical indications and pathologico-anatomic findings in the mastectomy specimen].
    Müller A; Tschahargane C; Kubli F; von Fournier D
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):687-93. PubMed ID: 2853092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subcutaneous mastectomy: the importance of the histopathological assessment technic].
    Müller A; Tschahargane C; Kubli F
    Dtsch Med Wochenschr; 1984 Jan; 109(2):50-4. PubMed ID: 6319103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
    Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical tactics in precancerous conditions and non-invasive cancers of the breast].
    Herfarth C; Schlag P
    Chirurg; 1982 Jan; 53(1):29-33. PubMed ID: 6277574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
    Hoogerbrugge N; Bult P; de Widt-Levert LM; Beex LV; Kiemeney LA; Ligtenberg MJ; Massuger LF; Boetes C; Manders P; Brunner HG
    J Clin Oncol; 2003 Jan; 21(1):41-5. PubMed ID: 12506168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast carcinoma-in-situ: an emerging problem in Singapore.
    Chua CL; Tan PK; Chiang G; Soo KC; Low CH
    Singapore Med J; 1992 Aug; 33(4):383-5. PubMed ID: 1329232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
    Hardman PD; Worth A; Lee U; Baird RM
    Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous mastectomy in 80 patients with breast tumours. Indications, surgical results and pathological findings.
    Gynning I; Jacobsson S; Linell F; Rothman U; Ostberg G
    Acta Chir Scand; 1975; 141(6):488-94. PubMed ID: 171897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical technique of subcutaneous/skin preserving tumor-adapted mastectomy].
    Schoenegg WD; Peters U; Minguillon C; Hadijuana J; Lichtenegger W
    Zentralbl Gynakol; 1993; 115(7):309-16. PubMed ID: 8396290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobular carcinoma of the breast in situ and infiltrating.
    Wheeler JE; Enterline HT
    Pathol Annu; 1976; 11():161-88. PubMed ID: 188001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of carcinoma in situ of the breast].
    Raudrant D; Golfier F; Unger P
    Rev Fr Gynecol Obstet; 1990 Feb; 85(2):91-6. PubMed ID: 2157271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal carcinoma of the breast.
    von Rueden DG; Wilson RE
    Surg Gynecol Obstet; 1984 Feb; 158(2):105-11. PubMed ID: 6320480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
    Finkelstein SD; Sayegh R; Thompson WR
    Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer.
    Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W
    J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre-invasive tumors and precancerous conditions of the breast: subcutaneous mastectomy and reconstruction-plasty. Indications and results].
    Bohmert H
    Chirurg; 1984 Mar; 55(3):152-61. PubMed ID: 6325101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.